title: Potential impact of immunobiotechnology on cancer therapy.
abstract: Genetic engineering techniques allow large scale production of substances generated during the immune response and these may have therapeutic value by modifying the biological response to cancer.
mesh_terms: D001709:Biotechnology; D006801:Humans; D007109:Immunity; D007167:Immunotherapy / Q000639:trends*; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D008233:Lymphotoxin-alpha / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
chemical_list: D007376:Interleukin-2; D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons